Press Releases November 5, 2024: MaaT Pharma Provides Third Quarter 2024 Business and Financial Results and Announces Management Changes MaaT Pharma Provides Third Quarter 2024 Business and Financial Results and Announces Management Changes Completion…MaaT PharmaNovember 5, 2024
Press Releases October 15, 2024: MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute Graft-versus-Host Disease MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute…MaaT PharmaOctober 15, 2024
Event Portzamparc’s Biotech and Life Sciences Conference • October 8-9, 2024 – Portzamparc's Biotech and Life Sciences ConferenceMaaT PharmaOctober 3, 2024
Event Annual congress of the SEHH and SETH • October 24-26, 2024 – Annual congress of the SEHH and SETHMaaT PharmaOctober 3, 2024
Press Releases September 19, 2024: MaaT Pharma Publishes its Half Year 2024 Results and Provides a Business Update MaaT Pharma Publishes its Half Year 2024 Results and Provides a Business Update Positive…MaaT PharmaSeptember 19, 2024
Event Healthtech Innovation Days HTID#6 • September 17-18, 2024 – 2024 edition of HTID#6 by HealthTech For Care, dedicated to…MaaT PharmaSeptember 16, 2024
Press Releases September 9, 2024: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…MaaT PharmaSeptember 9, 2024
Press Releases September 4, 2024: MaaT Pharma To Present and Participate in Investor and Medical Conferences in September MaaT Pharma To Present and Participate in Investor and Medical Conferences in September Lyon, France,…MaaT PharmaSeptember 4, 2024
Event Lyon Pole Bourse Forum • September 24, 2024 – Lyon Pole Bourse Forum - ParticipationMaaT PharmaSeptember 4, 2024